Abstract |
Tea is one of the most popular beverages in the world and has been studied extensively as a health-promoting beverage that may act to prevent a number of chronic diseases and cancers. (-)- Epigallocatechin gallate [(-)-EGCG], a major component in green tea, is unstable under physiological conditions and methylation of (-)-EGCG by catechol-Omicron- methyltransferase (COMT) is a modification that reduces the biological activity of (-)-EGCG. In the current study, we hypothesized that suppression of COMT activity in human breast cancer cells could increase the proteasome-inhibitory potency of (-)-EGCG and therefore enhance its tumor cell growth-inhibitory activity. We first determined the COMT genotype and basal levels of COMT activity in various human breast cancer cell lines. Furthermore, when breast cancer MDA-MB-231 cells containing high COMT activity were tested, the diminished COMT activity apparently increased the effectiveness of (-)-EGCG via augmented proteasome inhibition and apoptosis induction. This study supplements the previous findings that methylated (-)-EGCG is less bioactive and supports the notion that COMT inhibition may increase the anti- cancer properties of tea polyphenols and the combination may serve as a novel approach or supplemental treatment for breast cancer chemotherapy.
|
Authors | Kristin Landis-Piwowar, Di Chen, Tak Hang Chan, Q Ping Dou |
Journal | Oncology reports
(Oncol Rep)
Vol. 24
Issue 2
Pg. 563-9
(Aug 2010)
ISSN: 1791-2431 [Electronic] Greece |
PMID | 20596647
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Catechol O-Methyltransferase Inhibitors
- Enzyme Inhibitors
- Flavonoids
- Phenols
- Polyphenols
- Proteasome Inhibitors
- Tea
- Catechin
- epigallocatechin gallate
- Catechol O-Methyltransferase
- Proteasome Endopeptidase Complex
|
Topics |
- Apoptosis
(drug effects)
- Breast Neoplasms
(drug therapy, pathology)
- Carcinoma
(drug therapy, pathology)
- Catechin
(administration & dosage, analogs & derivatives, pharmacology)
- Catechol O-Methyltransferase
(metabolism, physiology)
- Catechol O-Methyltransferase Inhibitors
- Cell Proliferation
(drug effects)
- Drug Evaluation, Preclinical
- Drug Synergism
- Enzyme Activation
(drug effects)
- Enzyme Inhibitors
(administration & dosage, pharmacology)
- Female
- Flavonoids
(administration & dosage, pharmacology)
- Humans
- Phenols
(administration & dosage, pharmacology)
- Polyphenols
- Proteasome Endopeptidase Complex
(metabolism)
- Proteasome Inhibitors
- Tea
(chemistry)
- Tumor Cells, Cultured
|